Pekin Hardy Strauss’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Pekin Hardy Strauss’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.12M	Buy	7,100 +2,975	+72%	+$402K	0.1%	206
2026 Q1	$527K	Sell	4,125 -30	-0.7%	-$3.75K	0.06%	295
2025 Q4	$507K	Buy	4,155 +469	+13%	+$53.8K	0.05%	274
2025 Q3	$369K	Buy	3,686 +1,031	+39%	+$92.9K	0.04%	300
2025 Q2	$220K	Sell	2,655 -500	-16%	-$39.9K	0.03%	333
2025 Q1	$256K	Hold	3,155	–	–	0.03%	304
2024 Q4	$284K	Buy	3,155 +675	+27%	+$65.4K	0.04%	301
2024 Q3	$245K	Hold	2,480	–	–	0.03%	302
2024 Q2	$230K	Buy	2,480 +225	+10%	+$20.2K	0.03%	290
2024 Q1	$214K	Buy	+2,255	New	+$209K	0.03%	298
2023 Q2	–	Sell	-8,688	Closed	-$662K	–	336
2023 Q1	$662K	Sell	8,688 -5,840	-40%	-$485K	0.09%	180
2022 Q4	$1.21M	Sell	14,528 -2,295	-14%	-$186K	0.17%	126
2022 Q3	$1.33M	Sell	16,823 -4,725	-22%	-$398K	0.21%	113
2022 Q2	$1.6M	Buy	21,548 +16,880	+362%	+$1.27M	0.23%	108
2022 Q1	$420K	Buy	+4,668	New	+$431K	0.05%	240

Other funds holding XBI

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

Pekin Hardy Strauss's XBI Position: Q2 2026 in Review

Pekin Hardy Strauss increased its State Street SPDR S&P Biotech ETF (XBI) stake by 72% in Q2 2026, buying an estimated $402K and bringing the position to 7,100 shares worth $1.12M. The position accounts for 0.1% of the portfolio, ranked #206.

Pekin Hardy Strauss first reported a position in XBI in Q1 2022 and has held it in 15 quarters since. The position peaked at $1.6M in Q2 2022. 934 funds tracked by Wall St. Rank hold XBI as of Q2 2026.

Pekin Hardy Strauss held 7,100 shares of State Street SPDR S&P Biotech ETF worth $1.12M as of Q2 2026.
Pekin Hardy Strauss bought 2,975 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $402K.
State Street SPDR S&P Biotech ETF made up 0.1% of Pekin Hardy Strauss's portfolio in Q2 2026, its #206 holding.
Pekin Hardy Strauss first reported a position in State Street SPDR S&P Biotech ETF in Q1 2022 and has held it in 15 quarters since.
Pekin Hardy Strauss's State Street SPDR S&P Biotech ETF position peaked at $1.6M in Q2 2022.
934 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.

Based on Pekin Hardy Strauss's 13F filing for Q2 2026, filed 30 Jul 2026.